MeSH tree: E02.095
A new treatment for patients with life-threatening infectious diseases is being pioneered in Melbourne by researchers at The Alfred and Monash University. VICPhage, a clinical partnership between The Alfred and Monash, is ...
5 hours ago
0
0
US health officials on Thursday greenlit a first-of-its-kind gene therapy to treat a rare form of hereditary hearing loss, a breakthrough that could pave the way for other such hearing impairment treatments.
19 hours ago
0
4
Restoring the gut microbiome to its youthful state may hold the key to slowing aging and preventing liver cancer, one of the fastest-growing cancers worldwide, according to a study to be presented at Digestive Disease Week ...
Apr 23, 2026
0
4
A combination blood stem cell and pancreatic islet cell transplant from an immunologically mismatched donor completely prevented or cured type 1 diabetes in mice in a study by Stanford Medicine researchers. Type 1 diabetes ...
Apr 23, 2026
0
7
Metabolic tumor volume—a biomarker derived from PET imaging—can more accurately predict progression-free survival for large B-cell lymphoma patients than the widely used International Prognostic Index. By identifying patients ...
Apr 22, 2026
0
1
In an increasingly digital world, millions of disabled people are being systematically excluded from critical services every day, from their medical records to bank accounts to emergency response systems. These services are ...
Apr 22, 2026
0
1
A new international study co-led by investigators from Mass General Brigham and the Eye & ENT Hospital of Fudan University shows that a gene therapy for a rare form of genetic deafness successfully restored hearing in most ...
Apr 22, 2026
0
6
At the International Society for Heart and Lung Transplantation (ISHLT) 46th Annual Meeting and Scientific Sessions, held from 22–25 April at the Metro Toronto Convention Center in Toronto, ON, Canada, transplant specialists ...
Apr 22, 2026
0
3
At the 46th Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation (ISHLT), held from April 22–25 at the Metro Toronto Convention Center in Toronto, ON, Canada, Eileen Hsich, ...
Apr 22, 2026
0
3
A single infusion of ciltacabtagene autoleucel (Carvykti) led to a 100% minimal residual disease (MRD)-negativity rate in patients with high-risk smoldering multiple myeloma, according to results from CAR-PRISM, a phase II ...
Apr 20, 2026
0
4
